An outbreak of human coronavirus OC43 infection and serological cross-reactivity with SARS coronavirus

Canadian Journal of Infectious Diseases and Medical Microbiology

Volumn 17, Issue 6, 2006, Pages 330-336

  Patrick, David M ^a   Petric, Martin ^a   Skowronski, Danuta M ^a   Guasparini, Roland ^b   Booth, Timothy F ^c   Krajden, Mel ^a   McGeer, Patrick ^d   Bastien, Nathalie ^c   Gustafson, Larry ^b   Dubord, Janet ^b   MacDonald, Diane ^a   David, Samara T ^c   Srour, Leila F ^c   Parker, Robert ^b   Andonov, Anton ^c   Isaac Renton, Judith ^a   Loewen, Nadine ^b   McNabb, Gail ^a   McNabb, Alan ^a   Goh, Swee Han ^a   Henwick, Scott ^e   Astell, Caroline ^f   Guo, Jian Ping ^d   Drebot, Michael ^c   Tellier, Raymond ^g   Plummer, Francis ^c   Brunham, Robert C ^a   more..

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b FRASER HEALTH AUTHORITY   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e SURREY MEMORIAL HOSPITAL   (Canada)

^f BRITISH COLUMBIA CANCER AGENCY   (Canada)

^g HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Coronavirus; Human coronavirus OC43; Outbreak; Respiratory infection; SARS coronavirus; SARS CoV; Severe acute respiratory syndrome

Indexed keywords

ANTIBODY; GUANINE NUCLEOTIDE BINDING PROTEIN; NUCLEOCAPSID PROTEIN;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; CORONAVIRUS; COUGHING; CROSS REACTION; DIAGNOSTIC TEST; FALSE POSITIVE RESULT; FEVER; GENETIC ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PNEUMONIA; PREVALENCE; RESPIRATORY TRACT INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARS CORONAVIRUS; SEROLOGY; VIRUS INFECTION;

EID: 33846357501     PISSN: 17129532     EISSN: None     Source Type: Journal    
DOI: 10.1155/2006/152612     Document Type: Article

References (35)

1. World Health Organization. Update 96 - Taiwan, China: SARS transmission interrupted in last outbreak area 〈www.who.int/csr/don/2003_07_05/en〉 (Version current at November 6, 2006).
2. Peiris JS, Lai ST, Poon LL, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003;361:1319-25.
3. Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953-66.
4. Drosten C, Gunther S, Preiser W, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003;348:1967-76.
5. Fouchier RA, Kuiken T, Schutten M, et al. Aetiology: Koch's postulates fulfilled for SARS virus. Nature 2003;423:240.
6. Drazen JM. SARS - looking back over the first 100 days. N Engl J Med 2003;349:319-20.
7. Poutanen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med 2003;348:1995-2005.
8. Varia M, Wilson S, Sarwal S, et al. Investigation of a nosocomial outbreak of severe acute respiratory syndrome (SARS) in Toronto, Canada. CMAJ 2003;169:285-92.
9. Enserink M. Infectious diseases. Unexplained false alarm may hold lessons. Science 2003;302:767.
10. Patrick R, Murray P, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH. Manual of Clinical Microbiology. Washington: ASM Press, 2003.
11. Adachi D, Johnson G, Draker R, et al. Comprehensive detection and identification of human coronaviruses, including the SARS-associated coronavirus, with a single RT-PCR assay. J Virol Methods 2004;122:29-36.
12. Bastien N, Normand S, Taylor T, et al. Sequence analysis of the N, P, M and F genes of Canadian human metapneumovirus strains. Virus Res 2003;93:51-62.
13. Guo JP, Petric M, Campbell W, McGeer PL. SARS corona virus peptides recognized by antibodies in the sera of convalescent cases. Virology 2004;324:251-6.
14. Gene sequence of the SARS Coronavirus (Frankfurt Strain). GenBank accession number AY291315. 〈www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db= nucleotide&val=31581502〉 (Version current at November 6, 2006).
15. Marra MA, Jones SJ, Astell CR, et al. The Genome sequence of the SARS-associated coronavirus. Science 2003;300:1399-404.
16. Gene sequence of human coronavirus OC43. GenBank accession number AY391777. 〈http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?db= nucleotide&val=37702815〉 (Version current at November 6, 2006).
17. Kamahora T, Soe LH, Lai MM. Sequence analysis of nucleocapsid gene and leader RNA of human coronavirus OC43. Virus Res 1989;12:1-9.
18. Health Canada. Public health management of SARS cases and contacts: Interim guidelines, 〈http://www.phac-aspc.gc.ca/sars-sras/pdf/ phmanagementofcases12-17_e.pdf〉 (Version current at November 12, 2006).
19. Fisher DA, Chew MH, Lim YT, Tambyah PA. Preventing local transmission of SARS: Lessons from Singapore. Med J Aust 2003;178:555-8.
20. Riley S, Fraser C, Donnelly CA, et al. Transmission dynamics of the etiological agent of SARS in Hong Kong: Impact of public health interventions. Science 2003;300:1961-6.
21. Birch CJ, Clothier HJ, Seccull A, et al. Human coronavirus OC43 causes influenza-like illness in residents and staff of aged-care facilities in Melbourne, Australia. Epidemiol Infect 2005;133:273-7.
22. El-Sahly HM, Atmar RL, Glezen WP, Greenberg SB. Spectrum of clinical illness in hospitalized patients with "common cold" virus infections. Clin Infect Dis 2000;31:96-100.
23. Vabret A, Mourez T, Gouarin S, Petitjean J, Freymuth F. An outbreak of coronavirus OC43 respiratory infection in Normandy, France. Clin Infect Dis 2003;36:985-9.
24. Skowronski DM, Petric M, Daly P, et al. Coordinated response to SARS, Vancouver, Canada. Emerg Infect Dis 2006;12:155-8.
25. World Health Organization. Summary of the discussion and recommendations of the SARS Laboratory Workshop, 22 October 2003. 〈www.who.int/csr/sars/ guidelines/en/SARSLabmeeting.pdf〉 (Version current at November 6, 2006).
26. Peiris JS, Yuen KY, Osterhaus AD, Stohr K. The severe acute respiratory syndrome. N Engl J Med 2003;349:2431-41.
27. Chan KH, Cheng VC, Woo PC, et al. Serological responses in patients with severe acute respiratory syndrome coronavirus infection and cross-reactivity with human coronaviruses 229E, OC43, and NL63. Clin Diagn Lab Immunol 2005;12:1317-21.
28. Che XY, Qiu LW, Liao ZY, et al. Antigenic cross-reactivity hetween severe acute respiratory syndrome-associated coronavirus and human coronaviruses 229E and OC43. J Infect Dis 2005:191:2033-7.
29. Cheng M, Chan CW, Cheung RC, et al. Cross-reactivity of antibody against SARS-coronavirus nucleocapsid protein with IL-11. Biochem Biophys Res Commun 2005;338:1654-60.
30. Maache M, Komurian-Pradel F, Rajoharison A, et al. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid-based Western blot assay were rectified hy the use of two subunits (S1 and S2) of spike for detection of antibody to SARS-CoV. Clin Vaccine Immunol 2006;13:409-14.
31. Wang Y, Chang Z, Ouyang J, et al. Profiles of IgG antibodies to nucleocapsid and spike proteins of the SARS-associated coronavirus in SARS patients. DNA Cell Biol 2005;24:521-7.
32. Centers for Disease Control and Prevention (CDC). Prevalence of IgG antibody to SARS-associated coronavirus in animal traders - Guangdong Province, China, 2003. MMWR Morb Mortal Wkly Rep 2003;52:986-7.
33. Zhong NS, Zheng BJ, Li YM, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People's Republic of China, in February, 2003. Lancet 2003;362:1353-8.
34. World Health Organization. New case of laboratory-confirmed SARS in Guangdong, China - update 5. 〈www.who.int/csr/don/2004_01_31/en〉 (Version current at November 6, 2006).
35. Chui L, Drebot M, Andonov A, Petrich A, Glushek M, Mahony J. Comparison of 9 different PCR primers for the rapid detection of severe acute respiratory syndrome coronavirus using 2 RNA extraction methods. Diagn Microbiol Infect Dis 2005;53:47-55.